The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:
- Acquired/Congenital Bone Marrow Failure
- Thalassemia/Hemoglobinopathies
- Transfusion Medicine
- New Therapies (Pharmacology)
- Infections of the Immunocompromised
- Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
- Thoracic Oncology (Head/Neck/Lung/Thyroid)
- and many more…
Learning Objectives
At the conclusion of this activity, the participant will be able to:
- Apply current/recommended hematology and oncology guidelines in clinical practice
- Perform differential diagnosis of complex clinical presentations related to hematologic and oncologic disorders
- Identify/apply current therapeutic options for specific hematologic and oncologic disorders
- Review and interpret up-to-date literature relevant to clinical practice in hematology and oncology
- Demonstrate knowledge of pathophysiology as it applies to management of hematology and oncology disorders
- Apply knowledge gained to the ABIM certification/recertification hematology and oncology examinations
Intended Audience
The activity was planned for fellows/trainees, practicing hematology and oncology specialists (MDs), and other professional affiliates (internists with an interest in hematology and oncology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of hematology and oncology medicine.
TOPICS / SPEAKERS
Molecular Genetics of Cancer – Nikhil Wagle, MD
Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD
Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD
Infections in Cancer Patients – Lindsey Baden, MD
Symptom Management in Patients with Cancer – Andrew J. Lawton, MD
Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF
Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
Acute Leukemias – Daniel J. DeAngelo, MD, PhD
Myelodysplastic Syndrome – Eric S. Winer, MD
Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
Myeloproliferative Syndromes – Ann M. Mullally, MD
Multiple Myeloma – Kenneth C. Anderson, MD
Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD
Low Grade Lymphomas – Caron A. Jacobson, MD
Aggressive Non-Hodgkin Lymphoma – Eric D. Jacobsen, MD
Hodgkin’s Lymphoma – Reid W. Merryman, MD
Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
Head and Neck Cancer – Robert I. Haddad, MD
Natural History, Screening, and Small Cell Lung Cancer – Bruce E. Johnson, MD
Management of Stage I-III Non Small Cell Lung Cancer – Mark Awad, MD, PhD
Management of Metastatic Non Small Cell Lung Cancer – Mark Awad, MD, PhD
Mesothelioma and Thymoma – David M. Jackman, MD
Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
Pancreatic Cancer – Brian M. Wolpin, MD
Hepatobiliary Cancer – James M. Cleary, MD, PhD
Anal Cancer & Colorectal Cancers Part 1 – Robert J. Mayer, MD
Colorectal Cancers Part 2 – Robert J. Mayer, MD
Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD
Testicular Cancer – Mark M. Pomerantz, MD
Renal and Bladder Cancer – Guru P. Sonpavde, MBBS
Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD
Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD
Melanoma – F. Stephen Hodi, MD
Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
Neuro-oncology – David A. Reardon, MD
Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
Management of Metastatic Breast Cancer – Adrienne G. Waks, MD
Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
Hematopoiesis and Cytokines – David T. Scadden, MD
Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD
Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
Anemia – An Overview – Robert Stern, MD
Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD
Immune Hemolytic Anemia – Richard M. Kaufman, MD
Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
Sickle Cell Disease – Maureen M. Achebe, MD, MPH
Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
Disorders of Neutrophils – Nancy Berliner, MD
Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
Hemophilia – Aric D. Parnes, MD
Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD
Transfusion Medicine for the Clinician – Walter H. Dzik, MD
Date of Original Release: June 30, 2022
Termination Date: June 30, 2025
Reviews
There are no reviews yet.